The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First UK experience of apalutamide in metastatic and non-metastatic prostate cancer outside of clinical trials.
 
Prantik Das
Honoraria - EUSA Pharma; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Pfizer
 
Rania Mohammed
No Relationships to Disclose
 
Naveed Sarwar
Consulting or Advisory Role - MSD Oncology
Speakers' Bureau - Eusa Pharma; Merck Serono; MSD Oncology
 
Omar Din
No Relationships to Disclose
 
Ankit Jain
No Relationships to Disclose
 
Jessica Davies
No Relationships to Disclose
 
Thangrarajh Mugunthan
No Relationships to Disclose
 
Ajith Nair
No Relationships to Disclose
 
Aruni Ghose
No Relationships to Disclose
 
Seheli Bandyopadhyay
No Relationships to Disclose
 
Roopesh Krishnappa
No Relationships to Disclose
 
Pooja Iyer
No Relationships to Disclose
 
Lauren Jones
No Relationships to Disclose
 
Nikhil Vasdev
No Relationships to Disclose
 
Maja Moldawa
No Relationships to Disclose
 
Rebecca Devine
No Relationships to Disclose
 
Robert Hughes
No Relationships to Disclose
 
Anand Sharma
Consulting or Advisory Role - BMS; MSD Oncology
Speakers' Bureau - BMS GmbH & Co. KG; Eisai/MSD; EUSA Pharma; ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Pfizer/EMD Serono
Travel, Accommodations, Expenses - EUSA Pharma; EUSA Pharma; Ipsen; MSD